Newsletter Subject

If Not NOW, Then When?

From

pennypro.com

Email Address

jeff@pennypro.com

Sent On

Sun, Apr 17, 2022 02:06 PM

Email Preheader Text

Hey Trader, Read this in full detail. There are a number of catalysts set to set the biotech and pha

Hey Trader, Read this in full detail. There are a number of catalysts set to set the biotech and pharma industry into a frenzy. For health care stocks traders like myself, it’s going to be filled with opportunities. Not only that, but I’ve already come up with a number of forecasts I have for the industry and which specific stocks to keep on the radar. If you missed out on the Pharma Predictions event, then you can [watch the replay here](. Right now, [you can get in on the action and join Biotech Breakouts]( and learn all about the strategy I use to look to take advantage of all the catalyst plays to come. The good news: I’ve dropped the price to the lowest possible price point. It comes out to $799 for an annual subscription (just a tad over $2 a day). If you choose the 2nd year option — just $1197 — you get access to Biotech Breakouts for as long as it’s around. Here’s the catch — these prices will not be around forever. [The reason I wanted to lower the barriers to entry]( is because of all the catalysts set to hit the biotech and pharma market, and I don’t want you to miss out. NOW is the best time to learn how to trade biotech and pharma stocks. I genuinely believe you’ll be doing yourself a disservice if you don’t take advantage of the opportunity at hand. Consider yourself lucky because I’m keeping the prices this low. I’m not here to try and hinder your success. The thing is — if you miss even a month of learning how to trade biotechs and pharma stocks in 2022… you could miss out on a number of catalyst plays. So I will give you a bit of pressure here because I want the best for you. [Take advantage of these prices]( — and know these are the BEST PRICES Biotech Breakouts will be offered at. [Join right now, because this deal could end any moment now.]( If you have any reservations about jumping aboard, make sure to call my team at 410-775-6138, and tell them Jeff Williams sent you. Feel free to ask them what Biotech Breakouts is all about and what you’ll be getting with the service. Jeff Williams RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication.

Marketing emails from pennypro.com

View More
Sent On

27/02/2023

Sent On

12/05/2022

Sent On

11/05/2022

Sent On

11/05/2022

Sent On

10/05/2022

Sent On

10/05/2022

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.